Tenax Therapeutics Inc TENX:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 3:24 PM EST
1.17quote price arrow down-0.02 (-1.51%)
Volume
86,428
52 week range
1.01 - 3.68
Loading...
  • Open1.20
  • Day High1.22
  • Day Low1.15
  • Prev Close1.19
  • 52 Week High3.68
  • 52 Week High Date01/27/21
  • 52 Week Low1.01
  • 52 Week Low Date12/21/20

Key Stats

  • Market Cap29.53M
  • Shares Out25.20M
  • 10 Day Average Volume0.10M
  • Dividend-
  • Dividend Yield-
  • Beta2.19
  • YTD % Change-35.59

KEY STATS

  • Open1.20
  • Day High1.22
  • Day Low1.15
  • Prev Close1.19
  • 52 Week High3.68
  • 52 Week High Date01/27/21
  • 52 Week Low1.01
  • 52 Week Low Date12/21/20
  • Market Cap29.53M
  • Shares Out25.20M
  • 10 Day Average Volume0.10M
  • Dividend-
  • Dividend Yield-
  • Beta2.19
  • YTD % Change-35.59

RATIOS/PROFITABILITY

  • EPS (TTM)-5.06
  • P/E (TTM)-0.23
  • Fwd P/E (NTM)-2.63
  • EBITDA (TTM)-30.768M
  • ROE (TTM)-1,356.15%
  • Revenue (TTM)0.00
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date03/31/2022
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Tenax Therapeutics Inc

There is no recent news for this security.

Content From Our Affiliates

Profile

MORE
Tenax Therapeutics, Inc. is a specialty pharmaceutical company. The Company is focused on identifying, developing and commercializing products that address cardiovascular and pulmonary diseases of unmet medical need. The Company's products include TNX-103 (oral levosimendan) and TNX-201 (oral enteric coated imatinib). The Company's lead product, Levosimendan, is a calcium sensitizer/K-ATP activator developed for intravenous use in hospitalized patients with acutely...
Gerald Proehl
Non-Executive Chairman
Christopher Giordano
President
Eliot Lurier CPA
Chief Financial Officer
Address
One Copley Parkway, Suite 490
Morrisville, NC
27560
United States

Top Peers

SYMBOLLASTCHG%CHG
CNSP
CNS Pharmaceuticals Inc
1.02-0.03-3.30%
BLPH
Bellerophon Therapeutics Inc
2.77-0.05-1.73%
BPTH
Bio Path Holdings Inc
4.35+0.13+3.08%
MTCR
Metacrine, Inc.
1.27+0.10+8.55%
PALI
Palisade Bio Inc
2.07+0.08+3.77%